Mammalian Polyclonal IgG Antibody - Global Strategic Business Report

Global Mammalian Polyclonal IgG Antibody Market to Reach $1.6 Billion by 2030

The global market for Mammalian Polyclonal IgG Antibody estimated at US$1.5 Billion in the year 2022, is projected to reach a revised size of US$1.6 Billion by 2030, growing at a CAGR of 1.5% over the analysis period 2022-2030. Metabolic Markers, one of the segments analyzed in the report, is projected to record 2.4% CAGR and reach US$532.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Cardiac Markers segment is readjusted to a revised 1.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $395.1 Million, While China is Forecast to Grow at 5.8% CAGR

The Mammalian Polyclonal IgG Antibody market in the U.S. is estimated at US$395.1 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$381.8 Million by the year 2030 trailing a CAGR of 5.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at -1.5% and 0.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately -0.5% CAGR.

Select Competitors (Total 33 Featured) -

• Abbiotec, Inc.
• Advy Chemical Pvt. Ltd.
• BioNTech
• Abcam plc
• Bio-Rad Laboratories, Inc.
• Cell Signaling Technology, Inc.
• Cloud-clone corp.
• Creative Diagnostics
• Enzo Life Sciences, Inc.
• F. Hoffmann-La Roche Ltd
• FiberCell Laboratories
• Geno Technology Inc.
• Genway Biotech, Inc.
• LigaTrap
• Merck KGaA
• Phoenix Pharmaceuticals
• Proteintech Group
• Sino Biological Inc.
• Stemcell Technologies Inc.
• Thermo Fisher Scientific Inc.
• ViroGen

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year